By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Contact Information

Website: www.mimedx.com
Email: rborchert@mimedx.com
Main Phone: +1 770 651-9100
Address: 1775 West Oak Commons Court, NE
State: GA
City / Town: Marietta
Country: US
Postal Code: 30062

Issuer Information

Exchange: NSC
CEO: Timothy R. Wright
Employees: 735
NAICS: Surgical Appliance and Supplies Manufacturing(339113)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A